Income Statement
UPSTREAM BIO, INC.
UPB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
2.90 | 2.40 |
|
Cost of Revenue
|
- | - |
|
Gross Profit
|
2.90 | 2.40 |
|
Operating Expenses
|
163.22 | 80.13 |
|
Research & Development
|
136.81 | 62.97 |
|
Selling, General & Administrative
|
26.41 | 17.17 |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
-160.32 | -77.73 |
|
Non-Operating Income
|
16.92 | 14.96 |
|
Interest Income
|
16.93 | 12.12 |
|
Interest Expense
|
- | - |
|
Other Non-Op Income / Expense
|
- | - |
|
Income Before Tax
|
- | - |
|
Income Tax Expense
|
- | - |
|
Non-Controlling Interest
|
- | - |
|
Net Income
|
-143.44 | -62.81 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
-160.12 | -77.63 |
|
Earnings Per Share (Basic)
|
-2.66 | -5.58 |
|
Diluted EPS
|
-2.66 | -5.58 |
|
Weighted Average Shares
|
53.85 | 13.68 |
|
Diluted Weighted Avg Shares
|
53.85 | 13.68 |
|
Comprehensive Income
|
-142.89 | -62.85 |